1-39447679-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001394062.1(MACF1):c.19762-13A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 1,613,926 control chromosomes in the GnomAD database, including 33,080 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2431 hom., cov: 32)
Exomes 𝑓: 0.20 ( 30649 hom. )
Consequence
MACF1
NM_001394062.1 intron
NM_001394062.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.713
Publications
29 publications found
Genes affected
MACF1 (HGNC:13664): (microtubule actin crosslinking factor 1) This gene encodes a large protein containing numerous spectrin and leucine-rich repeat (LRR) domains. The encoded protein is a member of a family of proteins that form bridges between different cytoskeletal elements. This protein facilitates actin-microtubule interactions at the cell periphery and couples the microtubule network to cellular junctions. Alternative splicing results in multiple transcript variants, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, May 2013]
MACF1 Gene-Disease associations (from GenCC):
- lissencephaly 9 with complex brainstem malformationInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Ambry Genetics
- lissencephaly spectrum disorder with complex brainstem malformationInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-39447679-A-G is Benign according to our data. Variant chr1-39447679-A-G is described in ClinVar as [Benign]. Clinvar id is 1178452.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MACF1 | NM_001394062.1 | c.19762-13A>G | intron_variant | Intron 81 of 100 | ENST00000564288.6 | NP_001380991.1 | ||
MACF1 | NM_012090.5 | c.13585-13A>G | intron_variant | Intron 76 of 92 | NP_036222.3 | |||
MACF1 | NM_001397473.1 | c.7840-13A>G | intron_variant | Intron 24 of 40 | NP_001384402.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.160 AC: 24367AN: 152070Hom.: 2430 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24367
AN:
152070
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.189 AC: 47344AN: 250542 AF XY: 0.187 show subpopulations
GnomAD2 exomes
AF:
AC:
47344
AN:
250542
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.200 AC: 292877AN: 1461738Hom.: 30649 Cov.: 33 AF XY: 0.198 AC XY: 144125AN XY: 727182 show subpopulations
GnomAD4 exome
AF:
AC:
292877
AN:
1461738
Hom.:
Cov.:
33
AF XY:
AC XY:
144125
AN XY:
727182
show subpopulations
African (AFR)
AF:
AC:
1145
AN:
33480
American (AMR)
AF:
AC:
9683
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
6142
AN:
26136
East Asian (EAS)
AF:
AC:
6638
AN:
39700
South Asian (SAS)
AF:
AC:
9707
AN:
86248
European-Finnish (FIN)
AF:
AC:
10502
AN:
53414
Middle Eastern (MID)
AF:
AC:
900
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
237010
AN:
1111878
Other (OTH)
AF:
AC:
11150
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
14296
28592
42888
57184
71480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7970
15940
23910
31880
39850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.160 AC: 24364AN: 152188Hom.: 2431 Cov.: 32 AF XY: 0.158 AC XY: 11724AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
24364
AN:
152188
Hom.:
Cov.:
32
AF XY:
AC XY:
11724
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
1697
AN:
41556
American (AMR)
AF:
AC:
2867
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
788
AN:
3472
East Asian (EAS)
AF:
AC:
909
AN:
5182
South Asian (SAS)
AF:
AC:
518
AN:
4820
European-Finnish (FIN)
AF:
AC:
2166
AN:
10574
Middle Eastern (MID)
AF:
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14894
AN:
67996
Other (OTH)
AF:
AC:
369
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1029
2058
3087
4116
5145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
414
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Lissencephaly 9 with complex brainstem malformation Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.